Why Bionano Genomics Stock Popped Today
Shares of Bionano Genomics (NASDAQ: BNGO), a genome analysis specialist, have been on fire of late, skyrocketing by more than 1,500% over the past month. Jason McCarthy of Maxim Group, a firm that provides equity research among other services, raised his price target for Bionano Genomics' stock to $14 from $2; he also kept a buy rating on the stock. In his note, McCarthy mentioned the recent presentations Bionano Genomics held that focused in part on the company's Saphyr Optical Genome Mapping Instrument.
